Vaxcyte Inc :
pcvx
pcvx
Stock Data
$47.52
$0.93 (2.00%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Vaxcyte Inc, originally known as SutroVax, is a pioneering biotech firm focused on developing innovative protein vaccines aimed at combating bacterial infectious diseases. At the forefront of its pipeline is VAX-24, a promising vaccine candidate designed to prevent invasive pneumococcal disease. The company is also working on vaccines like VAX-31, VAX-A1, VAX-PG, and VAX-GI, targeting various bacterial pathogens and conditions, including antibiotic resistance and periodontitis. Founded in 2013 and based in San Carlos, California, Vaxcyte is committed to advancing vaccine science to protect global health.
All pcvx Articles
2 Articles
